logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9095609 B1

PDFFull Text
Date of Patent:
Aug. 04, 2015

Filed:

Sep. 08, 2011

Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia

Applicants:

Carlos Belmonte Martnez, San Joan d'Alacant, ES;

Juana Gallar Martinez, San Joan d'Alacant, ES;

Antonio Ferrer Montiel, San Joan d'Alacant, ES;

Asia Fernández Carvajal, San Joan d'Alacant, ES;

Félix Viana DE LA Iglesia, San Joan d'Alacant, ES;

Inventors:

Carlos Belmonte Martnez, San Joan d'Alacant, ES;

Juana Gallar Martinez, San Joan d'Alacant, ES;

Antonio Ferrer Montiel, San Joan d'Alacant, ES;

Asia Fernández Carvajal, San Joan d'Alacant, ES;

Félix Viana De La Iglesia, San Joan d'Alacant, ES;

Assignees:

UNIVERSIDAD MIGUEL HERNÁNDEZ DE ELCHE, , ES;

CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (C.S.I.C.), , ES;

Attorney:

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Primary Examiner:

Robert Landsman

Int. Cl.
CPC ...
A01N 31/08 (2006.01); A61K 31/05 (2006.01); A01N 33/18 (2006.01); A01N 33/24 (2006.01); A61K 31/04 (2006.01); A01N 27/00 (2006.01); A61K 31/015 (2006.01); A61K 45/00 (2006.01); A61K 31/00 (2006.01); A61K 31/045 (2006.01); A61K 31/047 (2006.01); A61K 31/075 (2006.01); A61K 31/16 (2006.01); A61K 31/164 (2006.01); A61K 31/167 (2006.01); A61K 31/17 (2006.01); A61K 31/196 (2006.01); A61K 31/215 (2006.01); A61K 31/22 (2006.01); A61K 31/221 (2006.01); A61K 31/245 (2006.01); A61K 31/27 (2006.01); A61K 31/352 (2006.01); A61K 31/357 (2006.01); A61K 31/381 (2006.01); A61K 31/4025 (2006.01); A61K 31/4164 (2006.01); A61K 31/4745 (2006.01); A61K 31/496 (2006.01); A61K 31/505 (2006.01); A61K 31/55 (2006.01); A61K 31/662 (2006.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01);
U.S. Cl.
CPC ...
A61K 45/00 (2013.01); A61K 31/00 (2013.01); A61K 31/045 (2013.01); A61K 31/047 (2013.01); A61K 31/075 (2013.01); A61K 31/16 (2013.01); A61K 31/164 (2013.01); A61K 31/167 (2013.01); A61K 31/17 (2013.01); A61K 31/196 (2013.01); A61K 31/215 (2013.01); A61K 31/22 (2013.01); A61K 31/221 (2013.01); A61K 31/245 (2013.01); A61K 31/27 (2013.01); A61K 31/352 (2013.01); A61K 31/357 (2013.01); A61K 31/381 (2013.01); A61K 31/4025 (2013.01); A61K 31/4164 (2013.01); A61K 31/4745 (2013.01); A61K 31/496 (2013.01); A61K 31/505 (2013.01); A61K 31/55 (2013.01); A61K 31/662 (2013.01); A61K 31/713 (2013.01); A61K 31/7105 (2013.01);
Abstract

The invention relates to therapeutic compositions for the treatment of dry eye, more specifically to compositions comprising a TRPM8 receptor agonist ligand. Furthermore, the invention relates to therapeutic compositions for the treatment of epiphora, more specifically to compositions comprising a TRPM8 receptor antagonist.

Find Patent Forward Citations

Loading…